Trademark Overview
On Wednesday, May 10, 2023, a trademark application was filed for IMMPRAIM with the United States Patent and Trademark Office. The USPTO has given the IMMPRAIM trademark a serial number of 97929125. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, February 5, 2024. This trademark is owned by Immunocore Limited. The IMMPRAIM trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers